PF-Atlas › Clinical Trials › NCT00047658

A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis

Interferon-gamma 1b · Phase 2

Registry ID
NCT00047658
Phase
Phase 2
Status
Completed
Drug / intervention
Interferon-gamma 1b
Sponsor
InterMune
Start
2001-11

About this trial

Interferon-gamma 1b is evaluated in NCT00047658, a Phase 2 idiopathic pulmonary fibrosis study sponsored by InterMune. Current status: Completed.

View NCT00047658 on ClinicalTrials.gov →

Explore related

All Interferon-gamma 1b trialsAll IPF trials

Related trials

interferon-gamma 1b — NCT00052052Interferon-gamma 1b — NCT00047645
Medical disclaimer. This page summarizes public trial data for NCT00047658 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.